The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Older adult guidelines: What is patient reported experience across five cancer programs?
 
Lindsey Bandini
No Relationships to Disclose
 
Christine B. Weldon
Consulting or Advisory Role - Genentech (Inst)
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); National Comprehensive Cancer Network (Inst); Pfizer (Inst); The Merck Foundation (Inst)
Travel, Accommodations, Expenses - Genentech (Inst)
 
Julia R. Trosman
Consulting or Advisory Role - Genentech (Inst)
Research Funding - Genentech (Inst); National Comprehensive Cancer Network (Inst); Pfizer (Inst); Pfizer (Inst); The Merck Foundation (Inst)
 
Sheetal Mehta Kircher
Stock and Other Ownership Interests - Abbott/AbbVie; Penrose
 
Nisha Anjali Mohindra
Consulting or Advisory Role - G1 Therapeutics
Research Funding - Pfizer (Inst)
 
Al Bowen Benson
Consulting or Advisory Role - Abbvie; Apexigen; Array BioPharma; Artemida Pharma; Bristol-Myers Squibb; HalioDx; Janssen Oncology; Merck Sharp & Dohme; Natera; Pfizer; Samsung Bioepis; Therabionic; Xencor
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Elevar Therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITM Solucin (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Rafael Pharmaceuticals (Inst); st pharm (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tyme Inc (Inst); Xencor (Inst)